UniSa - IRIS Institutional Research Information System

MANDATO, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.869
NA - Nord America 3.218
EU - Europa 1.158
SA - Sud America 343
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 8.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.176
HK - Hong Kong 2.837
SG - Singapore 383
IT - Italia 339
BR - Brasile 296
CN - Cina 285
RU - Federazione Russa 237
UA - Ucraina 160
VN - Vietnam 138
IE - Irlanda 104
DE - Germania 101
KR - Corea 52
TR - Turchia 47
FI - Finlandia 44
IL - Israele 41
SE - Svezia 40
IN - India 32
AT - Austria 28
GB - Regno Unito 27
NL - Olanda 21
CA - Canada 18
MX - Messico 16
AR - Argentina 15
BD - Bangladesh 12
CZ - Repubblica Ceca 10
PL - Polonia 10
FR - Francia 9
ES - Italia 8
ID - Indonesia 8
EC - Ecuador 7
IQ - Iraq 6
PE - Perù 6
ZA - Sudafrica 6
CO - Colombia 5
EU - Europa 5
JP - Giappone 5
VE - Venezuela 5
PK - Pakistan 4
PY - Paraguay 4
UZ - Uzbekistan 4
BY - Bielorussia 3
KE - Kenya 3
LT - Lituania 3
SV - El Salvador 3
TN - Tunisia 3
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MW - Malawi 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
UG - Uganda 1
YT - Mayotte 1
Totale 8.618
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.831
Ann Arbor 567
Dallas 320
Woodbridge 317
Chandler 288
Princeton 222
Jacksonville 191
Singapore 172
Wilmington 167
Ashburn 164
Houston 145
Dublin 96
Naples 89
Dong Ket 76
Beijing 51
Moscow 50
Nanjing 41
Izmir 40
Dearborn 39
Andover 35
Boardman 35
Los Angeles 34
Pellezzano 33
Salerno 30
Washington 26
Ho Chi Minh City 24
Mestre 23
Munich 19
Vienna 19
Brooklyn 18
São Paulo 18
Nuremberg 17
Düsseldorf 16
Santa Clara 16
Shenyang 16
The Dalles 16
Amsterdam 14
Hanoi 14
San Francisco 14
Council Bluffs 13
Norwalk 13
Pune 13
Seattle 13
Fairfield 12
Stockholm 12
New York 11
Rome 11
Seoul 11
West Jordan 11
Brno 10
Hebei 10
Jiaxing 10
Chicago 9
Tianjin 9
Atlanta 8
Chennai 8
Columbus 8
Nanchang 8
Rio de Janeiro 8
San Diego 8
Warsaw 8
Curitiba 6
Lappeenranta 6
London 6
Phoenix 6
Arba 5
Brasília 5
Charlotte 5
Denver 5
Eboli 5
Haiphong 5
Helsinki 5
Nola 5
Redwood City 5
Shanghai 5
Tokyo 5
Turku 5
Belo Horizonte 4
Boston 4
Cambridge 4
Caserta 4
Catania 4
Diadema 4
Edinburgh 4
Esslingen am Neckar 4
Frankfurt am Main 4
Goiânia 4
Johannesburg 4
Joinville 4
Juiz de Fora 4
Manaus 4
Milan 4
Ottawa 4
Ribeirão Preto 4
Springfield 4
Tashkent 4
Vancouver 4
Ankara 3
Aracaju 3
Baghdad 3
Totale 6.700
Salva come PNG Salva come JPEG
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 714
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 343
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 327
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 310
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 281
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 229
A systematic review of pediatrics NAFLD therapy: year 2012 206
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 189
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 185
Humanization interventions in general pediatric wards: a systematic review 162
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 145
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 143
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 140
Atypical celiac disease presenting as obesity-related liver dysfunction. 132
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 129
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 125
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 118
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 117
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 114
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 113
Autoimmune manifestations in pediatric liver transplantation recipients 112
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 110
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 107
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 105
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 100
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 98
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 97
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 96
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 96
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 95
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 95
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 93
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 92
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 91
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 91
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 90
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 89
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 89
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 89
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 87
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 86
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 81
More on vitamin E therapy 79
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 77
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 75
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 74
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 67
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 66
Global multi-stakeholder endorsement of the MAFLD definition 61
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 57
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 51
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 50
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 50
Nutrition and Liver Disease 48
Drug dosing in children with obesity: a narrative updated review 46
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 44
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 42
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 42
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 40
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 40
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 39
Genetics, epigenetics and transgenerational transmission of obesity in children 38
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 37
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 37
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 36
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 36
Ittero e feci ipocoliche: allarme atresia delle vie biliari 35
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 35
The gut-liver axis as a target of liver disease management 35
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 33
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 33
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 33
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 32
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 32
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 31
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 31
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 31
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 29
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 29
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 27
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 26
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 25
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis” 24
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 24
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 24
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 23
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 23
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 23
An almost accidentally diagnosis 23
Emerging, re‐emerging and/or atypically behaving infectious diseases 23
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 22
An odd septic arthritis of the hip 22
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 21
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 21
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 21
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 20
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 20
Nutritional therapy in liver transplantation 20
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 19
Italian children seem to be spared from the mysterious severe acute hepatitis outbreak: A report by SIGENP Acute Hepatitis Group 19
Totale 8.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.122
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021270 0 0 0 1 35 9 33 4 50 7 44 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20263.839 375 1.840 1.514 110 0 0 0 0 0 0 0 0
Totale 8.810